Seiwerth S, Rucman R, Turkovic B, Sever M, Klicek R, Radic B, Drmic D, Stupnisek M, Misic M, Vuletic LB, Pavlov KH, Barisic I, Kokot A, Japjec M, Blagaic AB, Tvrdeic A, Rokotov DS, Vrcic H, Staresinic M, Sebecic B, Sikiric P
The reduction in visceral fat, which is strongly associated with insulin resistance, provides additional metabolic benefits
Both oral and injectable formulations offer benefits but they differ in delivery, bioavailability, and patient suitability
Under sub-optimal conditions warm ambient temperatures, frequent puncture without consistent aseptic technique, light exposure the effective preservation window may shorten to less than 28 days even though the calendar window has not elapsed
Anecdotal reports of users running 6+ months show continued effectiveness without significant issues